NCT00103558 2015-10-02
Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Biogen
Phase 1/2 Completed
Clinical Trials
3 trialsNCT00046488 2013-09-16
Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Biogen
Phase 1 Completed
NCT00058396 2013-05-30
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed